Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yufang Bao
Institutions:
Shanghai Medical College of Fudan University,
Fudan University
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Shanghai University of Traditional Chinese Medicine,
Henan Medical University
ORCID:
0000-0002-8348-0948
Observed ORCID:
0000-0002-8348-0948
OpenAlex ID:
A5012690490
Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing
2017
·
Jiawei Zhao
, Yue Sun
, et al.
·
Scientific Reports
·
96
PDF
RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H
2020
·
Sirui Zhang
, Yufang Bao
, et al.
·
EBioMedicine
·
61
PDF
Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay
2017
·
Yue Sun
, Yufang Bao
, et al.
·
Nucleic Acids Research
·
59
PDF
PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C
2023
·
Nan Xu
, Yunpeng Ren
, et al.
·
Cell Reports
·
54
Splicing dysregulation in cancer: from mechanistic understanding to a new class of therapeutic targets
2020
·
Yongbo Wang
, Yufang Bao
, et al.
·
Science China Life Sciences
·
47
RBM10 Loss Promotes EGFR -Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2023
·
Yufang Bao
, Sirui Zhang
, et al.
·
Cancer Research
·
39
Evaluation of GREM1 and THBS2 as prognostic markers in in non-small cell lung cancer
2023
·
Yufang Bao
, Ershuai Yan
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
17
PDF
RNA splicing alterations in lung cancer pathogenesis and therapy
2023
·
Yueren Yan
, Yunpeng Ren
, et al.
·
Cancer Pathogenesis and Therapy
·
16
Splicing Shift of RAC1 Accelerates Tumorigenesis and Defines a Potent Therapeutic Target in Lung Cancer
2025
·
Yueren Yan
, Ning Wang
, et al.
·
Advanced Science
·
5
TLR10 expression in unswitched memory B associates with the disease activity of patients with systemic lupus erythematosus
2024
·
Lumin Zhang
, Linchang Yu
, et al.
·
Clinical Rheumatology
·
5
Prognostic and therapeutic potential of gene profiles related to tertiary lymphoid structures in colorectal cancer
2024
·
Jinglu Yu
, Yabin Gong
, et al.
·
PeerJ
·
3
A novel mouse cell line model reveals the tumor intrinsic and immune characteristics of EGFR-mutant lung cancer
2025
·
Yueren Yan
, Jun Shang
, et al.
·
Theranostics
·
2
PDF
Supplementary Data from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
PDF
Supplementary Table S4 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S5 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S2 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S3 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S1 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S1 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Data from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Data from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S3 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S4 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Data from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S5 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Show more works
View as search
Works count:
40
Citation count:
404
H-index:
8
I10-index:
8
Year
Topic
Type